By rectifying gut microbiota microenvironment dysbiosis, FMT reinstates a balanced microbial ecosystem, influencing key targets such as the Sig-1R and NLRP3 inflammasome, which are implicated in neuroinflammatory and neurochemical pathways associated with depressive disorders. Here, SIGMAR1 is linked to depressive disorder.